123 results
Page 3 of 7
424B3
diaq43
4 Apr 23
Prospectus supplement
4:57pm
POS AM
EX-23.1
jj920r7n iet5g
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
POS AM
0kms47p8qj6sd9slg
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
zo1t8pnnz1 psj3
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
8-K
0yyt8wnctp
29 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
EX-10.1
557oo5
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B5
nsokhvc
16 May 22
Prospectus supplement for primary offering
9:47pm
DEFA14A
hw4dzf6qwge
3 May 22
Additional proxy soliciting materials
10:33am
PRE 14A
ac9nxgez
21 Apr 22
Preliminary proxy
4:33pm
S-3
54n98z8
7 Feb 22
Shelf registration
12:00am
S-3
EX-23.1
3jm5o9 n9ij8rtdgyf20
7 Feb 22
Shelf registration
12:00am
S-3
EX-4.2
el7icl fs7vwxv7r
7 Feb 22
Shelf registration
12:00am
S-8
EX-23.1
vt9et1mslk
15 Sep 21
Registration of securities for employees
4:55pm
8-K
k5qep31ec7r5t
29 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
424B4
0npj kk0vi
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
1za9x1lt3q7k
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am